title: Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.
authors.affiliation: University Eye Hospital, Munich, Germany.
authors.forename: S A
authors.initials: SA
authors.lastname: Geier
authors.forename: M
authors.initials: M
authors.lastname: Held
authors.forename: J R
authors.initials: JR
authors.lastname: Bogner
authors.forename: U
authors.initials: U
authors.lastname: Kronawitter
authors.forename: T
authors.initials: T
authors.lastname: Berninger
authors.forename: V
authors.initials: V
authors.lastname: Klauss
authors.forename: F D
authors.initials: FD
authors.lastname: Goebel
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000328:Adult; D003117:Color Vision Defects / Q000139:chemically induced*; D015350:Contrast Sensitivity / Q000187:drug effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015215:Zidovudine / Q000009:adverse effects*
chemical_list: D015215:Zidovudine